UCI-HVB WAR. CALL 22 GS7/ DE000HB154B4 /
5/27/2022 9:45:00 PM | Chg.-0.3200 | Bid9:59:49 PM | Ask9:59:49 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.6000EUR | -8.16% | 3.5500 Bid Size: 1,000 |
3.6600 Ask Size: 1,000 |
Glaxosmithkline PLC ... | 14.50 GBP | 12/14/2022 | Call |
GlobeNewswire
3/25
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire
2/28
Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen’s 42nd Annual Health Care Co...
GlobeNewswire
2/28
Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones,...
GlobeNewswire
2/10
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
GlobeNewswire
12/14/2021
Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its...